Table of Contents: 1 Report Prologue 2 Market Introduction 2.1 Introduction 2.2 Assumptions & Limitations 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.4.1 Market Share Analysis 3.4.2 Market Pricing Approach 4 Market Dynamics 4.1 Introduction 4.1 Drivers 4.1.1 Increasing prevalence of actinic keratosis 4.1.2 Rising demand and acceptance of minimally invasive therapeutic procedures 4.1.3 Suitable medical coverage for a variety of treatment options available in the market 4.1.4 Growing geriatric population 4.1.5 Drivers Impact Analysis 4.2 Restraints 4.2.1 High cost of therapeutic procedures 4.2.2 Risk factors associated with the available treatment options in the market 4.2.3 Restraints Impact Analysis 4.3 Opportunity 4.3.1 Growing markets of Asia Pacific 4.4 Mega Trends 4.4.1 Application of cryosurgery in the therapeutics of actinic keratosis 4.5 Macroeconomic Indicator 5 Market Factor Analysis 5.1 Value Chain Analysis 5.1.1 R&D and Designing 5.1.2 Manufacturing 5.1.3 Distribution & Sales 5.1.4 Post-Sales Review 5.2 Porter’s Five Forces Model 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Buyers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitutes 5.2.5 Intensity of Rivalry 5.3 Investment Opportunities 5.4 Pricing Analysis 6 Global Actinic Keratosis Treatment Market, by Type 6.1 Introduction 6.1.1 Medications 6.1.2 Procedures 7 G lobal Actinic Keratosis Treatment Market, by End User 7.1 Introduction 7.1.1 Hospitals & Oncology Centers 7.1.2 Dermatology Clinics 7.1.3 Ambulatory Surgical Center 8 Global Actinic Keratosis Treatment Market, by Region 8.1 Introduction 8.2 Americas 8.2.1 North America 8.2.1.1 U.S 8.2.1.2 Canada 8.2.2 South America 8.3 Europe 8.3.1 Western Europe 8.3.1.1 Germany 8.3.1.2 France 8.3.1.3 U.K 8.3.1.4 Italy 8.3.1.5 Spain 8.3.1.6 Rest of Western Europe 8.3.2 Eastern Europe 8.4 Asia Pacific 8.4.1 China 8.4.1.1 India 8.4.2 Japan 8.4.3 Australia 8.4.4 Rest of Asia Pacific 8.5 Middle East & Africa 8.5.1 Middle East 8.5.2 Africa 9 Competitive Landscape 9.1 Introduction 10 Company Profiles 10.1 Biofrontera AG 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Products Offering 10.1.4 Key Developments 10.1.5 SWOT Analysis 10.1.6 Key Strategy 10.2 Cipher Pharmaceuticals Inc. 10.2.1 Company Overview 10.2.2 Financial Overview 10.2.3 Products Offering 10.2.4 Key Developments 10.2.5 SWOT Analysis 10.2.6 Key Strategy 10.3 BioLineRx. 10.3.1 Company Overview 10.3.2 Financial Overview 10.3.3 Products Offering 10.3.4 Key Developments 10.3.5 SWOT Analysis 10.3.6 Key Strategy   10.4 Valeant Pharmaceuticals. 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Products Offering 10.4.4 Key Developments 10.4.5 SWOT Analysis 10.4.6 Key Strategy 10.5 Leo Pharma 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Products Offering 10.5.4 Key Developments 10.5.5 SWOT Analysis 10.5.6 Key Strategy 10.6 Galderma S.A 10.6.1 Company Overview 10.6.2 Financial Overview 10.6.3 Products Offering 10.6.4 Key Developments 10.6.5 SWOT Analysis 10.6.6 Key Strategy 10.6.7 Sun Pharmaceutical Industries Ltd. 10.6.8 Company Overview 10.6.9 Products Offerings 10.6.10 Key Developments 10.6.11 SWOT Analysis 10.6.12 Key Strategy 10.7 3M 10.7.1 Company Overview 10.7.2 Products Offerings 10.7.3 Key Developments 10.7.4 SWOT Analysis 10.7.5 Key Strategy   10.8 Alma Lasers 10.8.1 Company Overview 10.8.2 Products Offerings 10.8.3 Key Developments 10.8.4 SWOT Analysis 10.8.5 Key Strategy 10.9 Stanford Chemicals 10.9.1 Company Overview 10.9.2 Financial Overview 10.9.3 Products Offering 10.9.4 Key Developments 10.9.5 SWOT Analysis 11 Conclusion 11.1 Key Findings 11.1.1 From CEO’s View Point 11.2 Key Companies to Watch 12 Appendix 12.1 Discussion Blue Print

List of Tables: TABLE 1 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 2 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR MEDICATIONS 2015-2024 (USD MILLION) TABLE 3 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR PROCEDURES 2015-2024 (USD MILLION) TABLE 4 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 5 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR HOSPITALS & ONCOLOGY CENTERS 2015-2024 (USD MILLION) TABLE 6 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR DERMATOLOGY CLINICS 2015-2024 (USD MILLION) TABLE 7 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR AMBULATORY SURGICAL CENTER 2015-2024 (USD MILLION) TABLE 8 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2015-2024 (USD MILLION) TABLE 9 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2017 (%) TABLE 10 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2015-2024 (USD MILLION) TABLE 11 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 12 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 13 NORTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 14 NORTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 15 U.S ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 16 U.S ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 17 CANADA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 18 CANADA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 19 SOUTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 20 SOUTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 21 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2015-2024 (USD MILLION) TABLE 22 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 23 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 24 WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 25 WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 26 GERMANY ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 27 GERMANY ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 28 FRANCE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 29 FRANCE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 30 U.K ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 31 U.K ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 32 ITALY ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 33 ITALY ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 34 SPAIN ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 35 SPAIN ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 36 REST OF WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 37 REST OF WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 38 EASTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 39 EASTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 40 ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2015-2024 (USD MILLION) TABLE 41 ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 42 ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 43 CHINA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 44 CHINA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 45 INDIA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 46 INDIA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 47 JAPAN ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 48 JAPAN ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 49 AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 50 AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 51 REST OF ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 52 REST OF ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 53 MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2015-2024 (USD MILLION) TABLE 54 MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 55 MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 56 MIDDLE EAST ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 57 MIDDLE EAST ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) TABLE 58 AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2015-2024 (USD MILLION) TABLE 59 AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2015-2024 (USD MILLION) List of Figures: FIGURE 1 MARKET STRUCTURE FIGURE 2 RESEARCH PROCESS FIGURE 3 DROC ANALYSIS OF THE GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FIGURE 5 RESTRAINTS IMPACT ANALYSIS: GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FIGURE 6 VALUE CHAIN: GLOBAL ACTINIC KERATOSES TREATMENT MARKET FIGURE 7 PORTERS FIVE FORCES MODEL: GLOBAL ACTINIC KERATOSES TREATMENT MARKET FIGURE 8 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2017 & 2024 (USD MILLION) FIGURE 9 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2017 & 2024 (USD MILLION) FIGURE 10 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2017 (%) FIGURE 11 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2017 (%) FIGURE 12 ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2017 (%) FIGURE 13 MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2017 (%) FIGURE 14 GLOBAL ACITNIC KERATOSES TREATMENT MAJOR PLAYERS MARKET SHARE ANALYSIS, 2017 (%)

The key players for the Actinic Keratosis treatment market are Biofrontera AG, Cipher Pharmaceuticals Inc, BioLineRx, Valeant Pharmaceuticals, Leo Pharma, Galderma S.A, Sun Pharmaceutical Industries Ltd, 3M, Alma Lasers and Stanford Chemicals and others